All In Biotech

Free tool

FAERS Monitor: Suflave

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 215344 or its brand name (Suflave, Magnesium Sulfate, Polyethylene Glycol 3350, Potassium Chloride, Sodium Chloride, Sodium Sulfate). Reports on generic versions are filed under their own applications.

Reports

108

Serious

15

14% of reports

Hospitalization

4

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea29
  • vomiting23
  • abdominal distension12
  • headache10
  • dehydration8
  • drug ineffective8
  • pruritus8
  • abdominal pain7
  • dizziness7
  • urticaria7
  • abdominal pain upper5
  • asthenia5
  • chills5
  • loss of consciousness5
  • abdominal discomfort4

Reports by year received

View as table
YearReports
20221
202439
202547
202621

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,051 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
abdominal distensionSignal1222.413.1225
dehydrationSignal811.76.068
vomitingSignal239.56.6171
chillsSignal58.33.525
urticariaSignal78.14.037
loss of consciousnessSignal57.63.223
nauseaSignal297.15.2153
abdominal painSignal75.92.924
abdominal pain upperSignal54.72.011
abdominal discomfortSignal44.61.88
pruritusSignal84.12.116
headacheSignal103.11.713
dizzinessSignal72.71.36
asthenia52.61.13
drug ineffective81.20.60

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.